B- and C-RAF Display Essential Differences in Their Binding to Ras

Recruitment of RAF kinases to the plasma membrane was initially proposed to be mediated by Ras proteins via interaction with the RAF Ras binding domain (RBD). Data reporting that RAF kinases possess high affinities for particular membrane lipids support a new model in which Ras-RAF interactions may be spatially restricted to the plane of the membrane. Although the coupling features of Ras binding to the isolated RAF RBD were investigated in great detail, little is known about the interactions of the processed Ras with the functional and full-length RAF kinases. Here we present a quantitative analysis of the binding properties of farnesylated and nonfarnesylated H-Ras to both full-length B- and C-RAF in the presence and absence of lipid environment. Although isolated RBD fragments associate with high affinity to both farnesylated and nonfarnesylated H-Ras, the full-length RAF kinases revealed fundamental differences with respect to Ras binding. In contrast to C-RAF that requires farnesylated H-Ras, cytosolic B-RAF associates effectively and with significantly higher affinity with both farnesylated and nonfarnesylated H-Ras. To investigate the potential farnesyl binding site(s) we prepared several N-terminal fragments of C-RAF and found that in the presence of cysteine-rich domain only the farnesylated form of H-Ras binds with high association rates. The extreme N terminus of B-RAF turned out to be responsible for the facilitation of lipid independent Ras binding to B-RAF, since truncation of this region resulted in a protein that changed its kinase properties and resembles C-RAF. In vivo studies using PC12 and COS7 cells support in vitro results. Co-localization measurements using labeled Ras and RAF documented essential differences between B- and C-RAF with respect to association with Ras. Taken together, these data suggest that the activation of B-RAF, in contrast to C-RAF, may take place both at the plasma membrane and in the cytosolic environment.

[1]  M. Matsuda,et al.  The amino‐terminal B‐Raf‐specific region mediates calcium‐dependent homo‐ and hetero‐dimerization of Raf , 2006, The EMBO journal.

[2]  Pablo Rodriguez-Viciana,et al.  Germline Mutations in Genes Within the MAPK Pathway Cause Cardio-facio-cutaneous Syndrome , 2006, Science.

[3]  W. Kolch,et al.  Regulation and Role of Raf-1/B-Raf Heterodimerization , 2006, Molecular and Cellular Biology.

[4]  R. Hennekam,et al.  Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome , 2006, Nature Genetics.

[5]  A. Blume,et al.  Live‐cell imaging of endogenous Ras‐GTP illustrates predominant Ras activation at the plasma membrane , 2006, EMBO reports.

[6]  D. Barford,et al.  Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization. , 2005, Molecular cell.

[7]  Volker Brinkmann,et al.  Prohibitin is required for Ras-induced Raf–MEK–ERK activation and epithelial cell migration , 2005, Nature Cell Biology.

[8]  Herbert Waldmann,et al.  An Acylation Cycle Regulates Localization and Activity of Palmitoylated Ras Isoforms , 2005, Science.

[9]  Ming Zhou,et al.  Regulation of Raf-1 by direct feedback phosphorylation. , 2005, Molecular cell.

[10]  L. Wennogle,et al.  Novel C‐Raf phosphorylation sites: serine 296 and 301 participate in Raf regulation , 2005, FEBS letters.

[11]  G. Shi,et al.  Rit Contributes to Nerve Growth Factor-Induced Neuronal Differentiation via Activation of B-Raf-Extracellular Signal-Regulated Kinase and p38 Mitogen-Activated Protein Kinase Cascades , 2005, Molecular and Cellular Biology.

[12]  R. Thapar,et al.  NMR characterization of full-length farnesylated and non-farnesylated H-Ras and its implications for Raf activation. , 2004, Journal of molecular biology.

[13]  J. Colicelli,et al.  Human RAS Superfamily Proteins and Related GTPases , 2004, Science's STKE.

[14]  Joachim Nickel,et al.  Dynamic Changes in C-Raf Phosphorylation and 14-3-3 Protein Binding in Response to Growth Factor Stimulation , 2004, Journal of Biological Chemistry.

[15]  J. Becker,et al.  Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis , 2004, Journal of carcinogenesis.

[16]  D. Barford,et al.  Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF , 2004, Cell.

[17]  D. Morrison,et al.  Regulation of MAP kinase signaling modules by scaffold proteins in mammals. , 2003, Annual review of cell and developmental biology.

[18]  T. Veenstra,et al.  Protein Phosphatase 2A Positively Regulates Ras Signaling by Dephosphorylating KSR1 and Raf-1 on Critical 14-3-3 Binding Sites , 2003, Current Biology.

[19]  N. Dumaz,et al.  Protein Kinase A Blocks Raf-1 Activity by Stimulating 14-3-3 Binding and Blocking Raf-1 Interaction with Ras* , 2003, Journal of Biological Chemistry.

[20]  P. Stork.  Does Rap1 deserve a bad Rap? , 2003, Trends in biochemical sciences.

[21]  J. Hancock,et al.  Ras proteins: different signals from different locations , 2003, Nature Reviews Molecular Cell Biology.

[22]  J. Nickel,et al.  Associations of B- and C-Raf with Cholesterol, Phosphatidylserine, and Lipid Second Messengers , 2002, The Journal of Biological Chemistry.

[23]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[24]  D. Andres,et al.  Induction of Neurite Extension and Survival in Pheochromocytoma Cells by the Rit GTPase* , 2002, The Journal of Biological Chemistry.

[25]  J. B. Sajous,et al.  Ras signalling on the endoplasmic reticulum and the Golgi , 2002, Nature Cell Biology.

[26]  Helmut E. Meyer,et al.  Conformational Switch and Role of Phosphorylation in PAK Activation , 2001, Molecular and Cellular Biology.

[27]  Robert G. Parton,et al.  GTP-dependent segregation of H-ras from lipid rafts is required for biological activity , 2001, Nature Cell Biology.

[28]  B Catimel,et al.  c-Raf-1 RBD associates with a subset of active v-H-Ras. , 2000, Biochemistry.

[29]  Simon C Watkins,et al.  The Recruitment of Raf-1 to Membranes Is Mediated by Direct Interaction with Phosphatidic Acid and Is Independent of Association with Ras* , 2000, The Journal of Biological Chemistry.

[30]  C. Der,et al.  Elucidation of Binding Determinants and Functional Consequences of Ras/Raf-Cysteine-rich Domain Interactions* , 2000, The Journal of Biological Chemistry.

[31]  C. Herrmann,et al.  Mitogenic signaling of Ras is regulated by differential interaction with Raf isozymes , 2000, Oncogene.

[32]  Herbert Waldmann,et al.  Bioorganic synthesis of lipid-modified proteins for the study of signal transduction , 2000, Nature.

[33]  Giulio Superti‐Furga,et al.  Serine and tyrosine phosphorylations cooperate in Raf‐1, but not B‐Raf activation , 1999, The EMBO journal.

[34]  M. Engelhard,et al.  Transient kinetic studies on the interaction of Ras and the Ras-binding domain of c-Raf-1 reveal rapid equilibration of the complex. , 1998, Biochemistry.

[35]  S. Feller,et al.  Activity of Rap1 Is Regulated by Bombesin, Cell Adhesion, and Cell Density in NIH3T3 Fibroblasts* , 1998, The Journal of Biological Chemistry.

[36]  C. Der,et al.  14-3-3 ζ Negatively Regulates Raf-1 Activity by Interactions with the Raf-1 Cysteine-rich Domain* , 1997, The Journal of Biological Chemistry.

[37]  Sandrine Roy,et al.  Activity of Plasma Membrane-recruited Raf-1 Is Regulated by Ras via the Raf Zinc Finger* , 1997, The Journal of Biological Chemistry.

[38]  H. Yao,et al.  cAMP Activates MAP Kinase and Elk-1 through a B-Raf- and Rap1-Dependent Pathway , 1997, Cell.

[39]  J. Avruch,et al.  An intact Raf zinc finger is required for optimal binding to processed Ras and for ras-dependent Raf activation in situ , 1997, Molecular and cellular biology.

[40]  R. Bell,et al.  Raf-1 Kinase Possesses Distinct Binding Domains for Phosphatidylserine and Phosphatidic Acid , 1996, The Journal of Biological Chemistry.

[41]  A. Wittinghofer,et al.  Quantitative structure-activity analysis correlating Ras/Raf interaction in vitro to Raf activation in vivo , 1996, Nature Structural Biology.

[42]  S. Yokoyama,et al.  Cysteine-rich Region of Raf-1 Interacts with Activator Domain of Post-translationally Modified Ha-Ras (*) , 1995, The Journal of Biological Chemistry.

[43]  A. Wittinghofer,et al.  The 2.2 Å crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with RaplA and a GTP analogue , 1995, Nature.

[44]  Alfred Wittinghofer,et al.  Quantitative Analysis of the Complex between p21 and the Ras-binding Domain of the Human Raf-1 Protein Kinase (*) , 1995, The Journal of Biological Chemistry.

[45]  M. Marshall,et al.  Substrate characterization of the Saccharomyces cerevisiae protein farnesyltransferase and type-I protein geranylgeranyltransferase. , 1994, Biochimica et biophysica acta.

[46]  D. Morrison,et al.  Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase , 1993, Molecular and cellular biology.

[47]  S. Elledge,et al.  Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1 , 1993, Nature.

[48]  U. Rapp,et al.  Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase. , 1992, Genes & development.

[49]  R. Goody,et al.  Expression of p21 proteins in Escherichia coli and stereochemistry of the nucleotide‐binding site. , 1986, The EMBO journal.

[50]  R. Götz,et al.  BuCy RAFs drive cells into MEK addiction. , 2006, Cancer cell.

[51]  X. F. Zhang,et al.  Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. , 2001, Recent progress in hormone research.